Loading clinical trials...

COMPLETEDNCT03893890

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

This is a Phase 2b, rollover, long-term study to evaluate the safety and duration of efficacy of EN3835 in the treatment of women with EFP. Subjects who participated in and completed studies EN3835-20...

Lead sponsor: Endo Pharmaceuticals•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETED

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

NCT05249257 · Cellulite, Laxity; Skin, and more

COMPLETEDPhase 2

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

NCT04580303 · Edematous Fibrosclerotic Panniculopathy, Cellulite, and more

COMPLETEDPhase 3

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women

NCT03446781 · Edematous Fibrosclerotic Panniculopathy (Cellulite)

COMPLETEDPhase 1

The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

NCT01518907 · Edematous Fibrosclerotic Panniculopathy, Cellulite

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 19, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment8

Start dateMar 2019

Last updatedJul 19, 2019

Condition

Edematous Fibrosclerotic Panniculopathy

Locations shown

Endo Clinical Trial Site #4

Clearwater, Florida

Endo Clinical Trial Site #1

Coral Gables, Florida

Endo Clinical Trial Site #5

Washington, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 19, 2019Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions